Live Breaking News & Updates on Medical oncology

Stay informed with the latest breaking news from Medical oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical oncology and stay connected to the pulse of your community

Awareness programme on cancer

Professor (Dr) Ajai Singh, Executive Director of AIIMS Bhopal, always emphasizes that we should go out of the hospital premises, among the people in the community to provide them health information.

Only then will we be able to truly make people health conscious. In view of the increasing cases of

Bhopal , Madhya-pradesh , India , Shashank-bansal , Ajai-singh , Orion-international-school , Department-of-medical-oncology , Executive-director , Assistant-professor , Medical-oncology , Orion-international , Awareness-programme-on-cancer

MDH, Everest masala row: 5 reasons to make spice blends at home and ditch the store-bought mix

Homemade spice blends offer a range of health benefits beyond enhancing flavour. From cancer prevention to managing hypertension, there are a range of benefits. | Health

Hong-kong , India , Bangalore , Karnataka , Mumbai , Maharashtra , Hyderabad , Andhra-pradesh , Singapore , Pritam-kataria , Punyashlok-ahilyadevi-holkar , Kanav-kumar

Decreasing Grade 3/4 Infections, Limited Hospitalizations Underscore Potential for Linvoseltamab in R/R Myeloma

Sundar Jagannath, MBBS, discusses linvoseltamab and expands on key efficacy and safety findings from the LINKER-MM1 trial in patients with relapsed/refractory multiple myeloma.

New-york , United-states , American , Sundar-jagannath , Tisch-cancer-institute-of-mount-sinai , Multiple-myeloma , Medical-oncology , Tisch-cancer-institute , Mount-sinai , Phase-1-2-linker-mm1-trial- , Nct03761108 , Linvoseltamab-

Dr Jain on Unmet Needs in the Treatment of Low- and High-Risk MDS

Akriti Jain, MD, discusses unmet needs in patients with low- and high-risk myelodysplastic syndromes.

Akriti-jain , Department-of-hematology , Medical-oncology , Cleveland-clinic , Myeloproliferative-neoplasms , Onclive-tv ,

Johnson & Johnson receives positive CHMP opinion for

This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...

Singapore , Belgium , Saclay , France-general- , France , Beerse , Region-flamande , United-states , American , Nicolas-girard , Henar-hevia , Institut-curie

Evercare Hospital Dhaka hosts colorectal cancer awareness patient forum

Evercare Hospital Dhaka recently organized a special patient forum to raise awareness about colorectal cancer, which is one of the leading causes of cancer-related deaths worldwide. The event was held on Wednesday and was attended by a diverse group of participants, including...

Bangladesh , Lutfull-chowdhury , Ratnadeep-chaskar , Vinay-kaul , Mohammad-farid-hossein , Shaila-perveen , Murshed-kabir , Arif-mahmud , Ferdous-shahriar-sayed , Commission-international , Gastroenterology-department , Evercare-hospital-dhaka-gastroenterology-hepatology-department

Immunome Appoints Sandra M. Swain to Board of Directors

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to its Board of...

United-states , American , Sandram-swain , Clay-siegall , University-of-florida , Investment-committee , American-society-of-clinical-oncology , National-cancer-institute , Medicine-at-vanderbilt-university , Genetic-medicine-at-medstar-health , Seagen-inc , National-institutes-of-health

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting

Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Chicago , Illinois , United-states , Boston , Massachusetts , American , Craige-devoe , Heather-divecchia , American-society-of-clinical-oncology , Securities-exchange , Nasdaq , Elicio-therapeutics-inc